Neogen Corporation Proceeds from Issuance of Other Long-term Debt
Neogen Corporation (NEOG) reported Proceeds from Issuance of Other Long-term Debt of -$750.00 thousand for the 9-month period ending 2012-02-29, per its 10-Q filed 2012-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt · last filed 2012-03-30
- Neogen Corporation proceeds from issuance of other long-term debt for the quarter ending 2012-02-29 was $104.00K, a 136.36% increase year-over-year.
- Neogen Corporation proceeds from issuance of other long-term debt for the quarter ending 2011-11-30 was -$768.00K, a 756.41% decline year-over-year.
- Neogen Corporation proceeds from issuance of other long-term debt for the quarter ending 2011-08-31 was -$86.00K, a 161.43% decline year-over-year.
- Neogen Corporation proceeds from issuance of other long-term debt for the quarter ending 2011-02-28 was $44.00K.
| Period end | Proceeds from Issuance of Other Long-term Debt 3 month | Proceeds from Issuance of Other Long-term Debt 6 month | Proceeds from Issuance of Other Long-term Debt 9 month |
|---|---|---|---|
| 2012-02-29 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | -$664.00K derived: sum of 2 quarters · filed 2012-03-30 | -$750.00K 10-Q · filed 2012-03-30 |
| 2011-11-30 | -$768.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | -$854.00K 10-Q · filed 2011-12-30 | |
| 2011-08-31 | -$86.00K 10-Q · filed 2011-09-30 | ||
| 2011-02-28 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $161.00K derived: sum of 2 quarters · filed 2012-03-30 | $301.00K 10-Q · filed 2012-03-30 |
| 2010-11-30 | $117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | $257.00K 10-Q · filed 2011-12-30 | |
| 2010-08-31 | $140.00K 10-Q · filed 2011-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |